Argus Research Reiterates Buy on Corteva, Maintains $91 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 90.4%

Neg 0% Neu 90.4% Pos 0%

Argus Research analyst Alexandra Yates reiterates Corteva (NYSE:CTVA) with a Buy and maintains $91 price target.

Comments

No comments yet. Be the first!